M&A news

BioDue Acquires Biokosmes to Enhance R&D and Expand Global Market Reach

Biokosmes acquired by BioDue

AcquisitionHealthcare

Get the full Biokosmes company profile

Access contacts, investors, buying signals & more

Open in Dashboard
Biokosmes logo
Acquired

Biokosmes

Personal Care Product Manufacturing

Undisclosed amount

May 13, 2025

BioDue logo
Acquirer

BioDue

Pharmaceutical Manufacturing

### BioDue Expands Its Portfolio: Acquires Biokosmes to Strengthen Position in Health & Personal Care Sector

In a strategic move poised to reshape the landscape of health and personal care manufacturing, BioDue has announced the acquisition of Biokosmes for an undisclosed amount. This acquisition promises to enhance BioDue’s capabilities in the competitive market of cosmetics and medical devices, while also streamlining Biokosmes’ operations under a larger umbrella.

Founded in 1983, Biokosmes began as a small galenic laboratory in Lecco, Italy, and rapidly evolved into a leading Contract Development and Manufacturing Organization (CDMO) in Europe. The company boasts over 40 years of experience and a robust pipeline of products in dermatology, intimate care, and oral care. Biokosmes has established itself as a reliable partner for over 70 clients across 60 countries, earning prestigious certifications from international regulatory bodies such as FDA and TGA.

On the other hand, BioDue has been a dominant player in the health and personal care sector, known for its innovative products and commitment to quality. By acquiring Biokosmes, BioDue aims to enhance its R&D capabilities and expand its manufacturing footprint, ensuring a more integrated approach to product development and production.

The strategic rationale behind this acquisition lies in the complementary strengths of both companies. BioDue will benefit from Biokosmes’ extensive experience in toll manufacturing and its established network of international clients. This partnership allows for shared expertise, driving innovation and efficiency while reducing time-to-market for new products.

The implications for the industry are significant. As consolidation becomes more prevalent among CDMOs, this acquisition may prompt other players to evaluate their competitive strategies, potentially leading to further mergers and acquisitions. The combined expertise of BioDue and Biokosmes could set a new standard for quality and sustainability in the sector, pushing competitors to elevate their own practices.

“This acquisition marks an exciting chapter for both BioDue and Biokosmes as we work together to innovate and deliver exceptional products,” said a hypothetical executive from BioDue. “Our shared commitment to quality and sustainability will drive us to new heights.”

As the health and personal care market evolves, the integration of Biokosmes into BioDue's operations signals a forward-thinking approach that prioritizes innovation, quality, and customer-centric solutions. Looking ahead, the synergistic capabilities of these two companies are likely to redefine industry standards and foster a more sustainable future for health and personal care manufacturing.

Buying signals & intent

Our AI suggests Biokosmes may be interested in:

R&D Services
Regulatory Consulting
Packaging Solutions
Microbiological Analysis
Market Trend Analysis

Unlock GTM signals

Discover Biokosmes's tech stack and active buying intent.

View GTM signals

Unlock key decision-makers

Get direct access to the decision-makers at Biokosmes.

Unlock decision-makers